Literature DB >> 17195915

Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma.

Akira Maki1, Hiroshi Kono, Mayetri Gupta, Masami Asakawa, Tetsuya Suzuki, Masanori Matsuda, Hideki Fujii, Ivan Rusyn.   

Abstract

BACKGROUND: This study evaluated the relationship between inflammation, intra-hepatic oxidative stress, oxidative DNA damage and the progression of liver carcinogenesis in hepatitis C virus (HCV)-infected humans.
METHODS: Non-cancerous liver tissues were collected from 30 patients with an HCV-associated solitary hepatocellular carcinoma (HCC) who received curative tumor removal. After surgery, the patients were followed at monthly intervals at the outpatient clinic. Distribution of the inflammatory cells (CD68+), the number of 8-hydroxydeoxyguanosine (8-OHdG) DNA adducts and 4-hydroxynonenal (HNE) protein adducts and the expression of apurinic/apyrimidinic endonuclease (APE) were determined by immunohistochemical analysis in serial liver sections from tumor-free parenchyma at the surgical margin around the tumor.
RESULTS: Significant positive correlations were observed between the number of CD68+ cells, the amount of HNE protein adducts, and the number of 8-OHdG adducts in liver tissue of patients with HCC and HCV. The cumulative disease-free survival was significantly shorter in patients with the highest percentage of 8-OHdG-positive hepatocytes. Using a Cox proportional hazard model, 8-OHdG, HNE and CD68 were determined to be good biomarkers for predicting disease-free survival in patients with HCC and HCV.
CONCLUSIONS: These results support the hypothesis that HCV-induced inflammation causes oxidative DNA damage and promotes hepatocarcinogenesis which directly affects the clinical outcome. Since patients with greater intra-hepatic oxidative stress had a higher incidence of HCC recurrence, we suggest that oxidative stress biomarkers could potentially be used as a useful clinical diagnostic tool to predict the duration of disease-free survival in patients with HCV-associated HCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17195915     DOI: 10.1245/s10434-006-9049-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  48 in total

Review 1.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

2.  Characteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinoma.

Authors:  Nobuyoshi Fukushima; Ryoko Kuromatsu; Jun Akiba; Eiji Ando; Akio Takata; Shuji Sumie; Masahito Nakano; Toru Nakamura; Akihiko Kawahara; Takuji Torimura; Osamu Nakashima; Koji Okuda; Hirohisa Yano; Masayoshi Kage; Masamichi Kojiro; Michio Sata
Journal:  Exp Ther Med       Date:  2010-07-21       Impact factor: 2.447

Review 3.  Prognostic value of red blood cell distribution width in hepatocellular carcinoma.

Authors:  Hemant Goyal; Zhi-De Hu
Journal:  Ann Transl Med       Date:  2017-07

4.  8-Hydroxy-2'-deoxyguanosine expression predicts hepatocellular carcinoma outcome.

Authors:  Shengmian Li; Xiaoling Wang; Yijuan Wu; Huijing Zhang; Lan Zhang; Cuiju Wang; Ruixing Zhang; Zhanjun Guo
Journal:  Oncol Lett       Date:  2011-11-10       Impact factor: 2.967

5.  Cardiac autonomic modulation impairments in advanced breast cancer patients.

Authors:  Claudia Arab; Luiz Carlos Marques Vanderlei; Laércio da Silva Paiva; Kyle Levi Fulghum; Carlos Elias Fristachi; Afonso Celso Pinto Nazario; Simone Elias; Luiz Henrique Gebrim; Celso Ferreira Filho; Yori Gidron; Celso Ferreira
Journal:  Clin Res Cardiol       Date:  2018-05-02       Impact factor: 5.460

6.  Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma.

Authors:  Masato Tsuchiya; Joel S Parker; Hiroshi Kono; Masanori Matsuda; Hideki Fujii; Ivan Rusyn
Journal:  Mol Cancer       Date:  2010-04-09       Impact factor: 27.401

Review 7.  Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment.

Authors:  Giuseppe Castello; Susan Costantini; Stefania Scala
Journal:  J Transl Med       Date:  2010-11-03       Impact factor: 5.531

8.  Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress.

Authors:  Masato Tsuchiya; Hiroshi Kono; Masanori Matsuda; Hideki Fujii; Ivan Rusyn
Journal:  Int J Cancer       Date:  2008-12-01       Impact factor: 7.396

9.  Mitochondrial DNA haplogroup M is associated with late onset of hepatocellular carcinoma.

Authors:  Zhanjun Guo; Hua Yang; Cuiju Wang; Shufeng Liu
Journal:  Exp Ther Med       Date:  2011-12-27       Impact factor: 2.447

10.  Hepatitis C and innate immunity: recent advances.

Authors:  Gyongyi Szabo; Angela Dolganiuc
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.